IRS2 and preeclampsia: This signaling transduction pathway is an important milestone in the molecular mechanisms for insulin resistance syndrome in patients with preeclampsia.9 Data from Scoscia suggested that there was significantly higher serine phosphorylation of IRS1 and IRS2 in insulin-treated samples from preeclampsia patients.